A comparison trial of diagnostic performance of simultaneous 68Gallium-HBED-CC-PSMA PET and multiparametric MRI with results of multiparametric MRI and PET alone.
Phase of Trial: Phase IV
Latest Information Update: 04 Jul 2016
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 04 Jul 2016 New trial record